Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Vizient, Inc.

< Previous 1 2 3 4 Next >
Vizient/AACN Nurse Residency Program announces integration of Maryland R3 curriculum
From Vizient, Inc.
Via Business Wire
Vizient conducts first Insight: Cell, Gene, and Specialty Pharmacy Symposium
From Vizient, Inc.
Via Business Wire
Fortune Media and Great Place To Work Name Vizient to ‘100 Best Companies to Work For’ in 2024
From Vizient, Inc.
Via Business Wire
Vizient Task Force Releases Recommendations for Hospitals on Preparing for an Active Shooter Event
From Vizient, Inc.
Via Business Wire
Vizient Announces Trends for Providers to Strategize in 2024
From Vizient, Inc.
Via Business Wire
Vizient Now Accepting Applications for 2024 Innovative Technology Exchange
From Vizient, Inc.
Via Business Wire
Vizient Projects 3.8% Drug Price Increase Driven by Specialty Pharmaceuticals
From Vizient, Inc.
Via Business Wire
Vizient Explores Cardiac Ablation Modalities, Advancements in Remote Patient Monitoring and Imaging Alternatives for Early Breast Cancer Detection
From Vizient, Inc.
Via Business Wire
For Pediatric Patient Population, Vizient Forecasts Growth in Obesity Services, Highlights Risk Factors for Asthma and Examines New RSV Vaccines
From Vizient, Inc.
Via Business Wire
Vizient Hosts Congressional Briefing on Mental and Behavioral Health
From Vizient, Inc.
Via Business Wire
Vizient Announces Acquisition of PrefTech OR, a Next-generation Physician Preference Card Management Technology
From Vizient, Inc.
Via Business Wire
Vizient Announces Top Performers in Clinical Quality, Supplier Diversity and Environmentally Preferred Sourcing Excellence
From Vizient, Inc.
Via Business Wire
Vizient Recognizes 22 Suppliers and Distributors for Service Excellence
From Vizient, Inc.
Via Business Wire
Vizient Examines Strategies to Retain Musculoskeletal Procedure Volume as Care Sites Shift
From Vizient, Inc.
Via Business Wire
Vizient Report on Chronic Kidney Disease Finds Wide Variation in Rate of Screening Among Patient Populations Affecting Outcomes
From Vizient, Inc.
Via Business Wire
Vizient Releases 2022 Diversity, Equity and Inclusion (DEI) Report
From Vizient, Inc.
Via Business Wire
Vizient: Lack of Information Across Supply Chain Exacerbating Oncology Drug Shortage
From Vizient, Inc.
Via Business Wire
Vizient’s Annual CSR Report Highlights Progress in Improving Health Equity and Sustainability in Healthcare Sector
From Vizient, Inc.
Via Business Wire
Vizient Grants Public Access to the Vizient Vulnerability Index™ for Healthcare Providers to Assess Health Equity in their Communities
From Vizient, Inc.
Via Business Wire
Vizient: Expansion of Specialty Drugs Driving a 3.42% Projected Increase in Hospital Pharmacy Spend
From Vizient, Inc.
Via Business Wire
Vizient Hosts Congressional Briefing on Social Determinants of Health
From Vizient, Inc.
Via Business Wire
Sg2 Forecasts Continued Hospital Capacity Challenges as Patient Acuity Rises Over the Next Decade
From Vizient, Inc.
Via Business Wire
Vizient, Ochsner Host Networking Event to Connect Gulf Coast Minority Businesses with Large Employers
From Vizient, Inc.
Via Business Wire
Vizient Leader Presents at the Inaugural CMS Health Equity Conference
From Vizient, Inc.
Via Business Wire
Vizient Examines Trends in Diagnostic Imaging, CT Advancements and Theranostics in Latest Tech Watch
From Vizient, Inc.
Via Business Wire
Vizient Announces New Agreement with TriHealth to Deliver Cost Savings
From Vizient, Inc.
Via Business Wire
Vizient Workforce Report Finds Nurse Turnover Rate 47% Higher Than Pre-Pandemic Levels
From Vizient, Inc.
Via Business Wire
Vizient Examines Care Models for Arrhythmia, How to Improve Screening Rates for Colorectal Cancer in Latest Medical Device Tech Watch
From Vizient, Inc.
Via Business Wire
Fortune Media and Great Place To Work® Name Vizient to 2023 Fortune 100 Best Companies to Work For®, Ranking No. 45
From Vizient, Inc.
Via Business Wire
Vizient to Share Insights on Biosimilars at Festival of Biologics
From Vizient, Inc.
Via Business Wire
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.